Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Crossover Experiments01:16

Crossover Experiments

4.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.7K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

312
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
312
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

676
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
676
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

339
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
339
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

880
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
880
Hazard Ratio01:12

Hazard Ratio

661
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
661

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes.

Diabetes, obesity & metabolism·2020
Same author

A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti-HERV-W-Env monoclonal antibody.

Diabetes, obesity & metabolism·2018
Same author

Meta-analysis combining parallel and crossover trials using generalised estimating equation method.

Research synthesis methods·2017
Same journal

Doubly robust augmented weighting estimators for the analysis of externally controlled single-arm trials and unanchored indirect treatment comparisons.

Research synthesis methods·2026
Same journal

Prompt engineering of large language models for paper screening in medical meta-analyses and systematic reviews: A prospective comparative study - CORRIGENDUM.

Research synthesis methods·2026
Same journal

Evaluating the accuracy and speed of eight deduplication tools: A comparative study.

Research synthesis methods·2026
Same journal

A comparison of preprint search aggregators: comprehensive identification of preprints in the information retrieval stage of evidence syntheses.

Research synthesis methods·2026
Same journal

Meta-research on key metrics of preregistered scoping reviews.

Research synthesis methods·2026
Same journal

Facilitators and barriers to engaging patient partners in knowledge syntheses: A stage-based approach.

Research synthesis methods·2026
See all related articles

Related Experiment Video

Updated: Mar 3, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K

Meta-analysis combining parallel and cross-over trials with random effects.

François Curtin1,2,3

  • 1Division of Clinical Pharmacology and Toxicology, Geneva University Hospital, Geneva, Switzerland.

Research Synthesis Methods
|April 22, 2017
PubMed
Summary
This summary is machine-generated.

This study presents a new statistical method to combine parallel and crossover trial designs in meta-analysis. This approach enhances statistical power by including diverse trial types, improving evidence synthesis.

Keywords:
Bayesiancross-overparallelrandom effectstrial design

More Related Videos

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI
06:26

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI

Published on: November 27, 2019

78.2K
Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR
06:18

Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR

Published on: July 11, 2025

968

Related Experiment Videos

Last Updated: Mar 3, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K
Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI
06:26

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI

Published on: November 27, 2019

78.2K
Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR
06:18

Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR

Published on: July 11, 2025

968

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Evidence Synthesis

Background:

  • Meta-analysis often excludes crossover trials due to design differences and potential biases, limiting statistical power.
  • Combining parallel and crossover designs can provide a more comprehensive evidence base.

Purpose of the Study:

  • To develop and present statistical models for combining parallel and crossover clinical trial designs in meta-analysis.
  • To account for random effects and covariates to address heterogeneity in treatment effects and interactions.

Main Methods:

  • Extension of a previously proposed method to incorporate random effects for mixed-design meta-analysis.
  • Development of a hierarchical mixed-effects model and a Bayesian hierarchical model.
  • Analysis using restricted iterative generalized least squares and Markov Chain Monte Carlo methods.

Main Results:

  • Demonstration of methods using a meta-analysis of salt reduction trials.
  • Comparison of the proposed models and discussion of their respective advantages.
  • Identification of data access, particularly sequence and period data from crossover trials, as a key limitation.

Conclusions:

  • The proposed hierarchical models offer a robust framework for combining parallel and crossover trial designs in meta-analysis.
  • These methods can increase the power and comprehensiveness of meta-analytic evidence synthesis.
  • Improved access to detailed crossover trial data is crucial for advancing combined-design meta-analysis.